The Growing Link Between HIV and Heart Disease
For decades, human immunodeficiency virus (HIV) was considered primarily an immune deficiency disorder. However, with advancements in antiretroviral therapy (ART) extending the lifespan of individuals living with HIV, a new challenge has emerged: an increased risk of cardiovascular disease (CVD). This article explores the complex relationship between HIV and heart health, examining the underlying causes, manifestations, and current understanding of this growing concern.
How HIV Impacts the Cardiovascular System
Even as ART has dramatically improved survival rates for people living with HIV, it hasn’t eliminated the increased risk of CVD. Several factors contribute to this vulnerability. Chronic inflammation, a hallmark of HIV even in those on effective ART, plays a significant role. Research suggests that persistent immune activation and inflammatory markers like interleukin-6 (IL-6) and C-reactive protein predict mortality in individuals with HIV.
Beyond inflammation, other mechanisms are at play. These include:
- Direct Viral Effects: HIV can directly infect heart cells, leading to myocardial dysfunction.
- ART-Related Factors: Some older antiretroviral medications were associated with metabolic abnormalities like high cholesterol and insulin resistance, increasing CVD risk. While newer ART regimens are generally safer, metabolic complications can still occur.
- Traditional Risk Factors: People with HIV may have a higher prevalence of traditional CVD risk factors like hypertension, smoking, and obesity.
- Trained Immunity: Studies indicate that trained immunity, a long-lasting alteration in immune cell function, may exacerbate inflammation in people with HIV.
Types of Cardiovascular Disease Seen in People with HIV
Individuals living with HIV are susceptible to a range of cardiovascular problems, including:
- Coronary Artery Disease: Narrowing of the arteries supplying the heart, leading to chest pain (angina) and heart attack.
- Heart Failure: The heart’s inability to pump enough blood to meet the body’s needs.
- Cardiomyopathy: Disease of the heart muscle, which can impair its ability to contract and pump blood effectively. Recent research focuses on unraveling the molecular mechanisms behind HIV-associated cardiomyopathy.
- Arrhythmias: Irregular heartbeats.
- Stroke: Disruption of blood flow to the brain.
Diagnosis and Management
Early detection and management of CVD in people with HIV are crucial. Advances in cardiac imaging modalities are improving diagnosis. Understanding the pathogenesis of HIV-associated CVD is also improving treatment strategies.
Management typically involves:
- Lifestyle Modifications: Healthy diet, regular exercise, smoking cessation.
- Medications: To control blood pressure, cholesterol, and other risk factors.
- ART Adherence: Maintaining viral suppression with ART is essential.
- Monitoring: Regular cardiovascular evaluations.
The Future of HIV and Heart Health
As the population of people living with HIV continues to age, the burden of CVD is expected to rise. Ongoing research is focused on understanding the complex interplay between HIV, inflammation, and cardiovascular risk. Further investigation into the molecular mechanisms driving HIV-associated cardiomyopathy and the role of trained immunity will be critical for developing targeted therapies and improving long-term outcomes for individuals living with HIV.
Worth a look